BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21404182)

  • 1. Faithful reprogramming to pluripotency in mammals - what does nuclear transfer teach us?
    Maruotti J; Jouneau A; Renard JP
    Int J Dev Biol; 2010; 54(11-12):1609-21. PubMed ID: 21404182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dedifferentiation of cells: new approaches.
    Collas P
    Cytotherapy; 2007; 9(3):236-44. PubMed ID: 17464755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein roadmap to pluripotency and faithful reprogramming.
    Wang J; Orkin SH
    Cells Tissues Organs; 2008; 188(1-2):23-30. PubMed ID: 18196921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of isogenic pluripotent stem cells.
    Byrne JA
    Hum Mol Genet; 2008 Apr; 17(R1):R37-41. PubMed ID: 18632695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear reprogramming in cells.
    Gurdon JB; Melton DA
    Science; 2008 Dec; 322(5909):1811-5. PubMed ID: 19095934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Akt signaling on nuclear reprogramming.
    Nakamura T; Inoue K; Ogawa S; Umehara H; Ogonuki N; Miki H; Kimura T; Ogura A; Nakano T
    Genes Cells; 2008 Dec; 13(12):1269-77. PubMed ID: 19032345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
    Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
    Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear transfer to study the nuclear reprogramming of human stem cells.
    Saito S; Sawai K; Murayama Y; Fukuda K; Yokoyama K
    Methods Mol Biol; 2008; 438():151-69. PubMed ID: 18369756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct reprogramming 101.
    Takahashi K
    Dev Growth Differ; 2010 Apr; 52(3):319-33. PubMed ID: 20298260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cells.
    Ambrosi DJ; Tanasijevic B; Kaur A; Obergfell C; O'Neill RJ; Krueger W; Rasmussen TP
    Stem Cells; 2007 May; 25(5):1104-13. PubMed ID: 17272499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular reprogramming of somatic cells.
    Sumer H; Liu J; Verma PJ
    Indian J Exp Biol; 2011 Jun; 49(6):409-15. PubMed ID: 21702219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear reprogramming in zygotes.
    Lorthongpanich C; Solter D; Lim CY
    Int J Dev Biol; 2010; 54(11-12):1631-40. PubMed ID: 21404184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation.
    Masip M; Veiga A; Izpisúa Belmonte JC; Simón C
    Mol Hum Reprod; 2010 Nov; 16(11):856-68. PubMed ID: 20616150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
    Li W; Ding S
    Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
    Ho PJ; Yen ML; Lin JD; Chen LS; Hu HI; Yeh CK; Peng CY; Lin CY; Yet SF; Yen BL
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advancements towards the derivation of immune-compatible patient-specific human embryonic stem cell lines.
    Drukker M
    Semin Immunol; 2008 Apr; 20(2):123-9. PubMed ID: 18160306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
    Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
    Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of reprogramming in cell fusion hybrids.
    Choi HW; Do JT
    Int J Dev Biol; 2010; 54(11-12):1697-702. PubMed ID: 21404190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.